Try our beta test site

Assessing Mental Illness Recovery (MARS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT01043653
First received: January 5, 2010
Last updated: January 25, 2017
Last verified: January 2017
Results First Received: November 10, 2016  
Study Type: Observational
Study Design: Observational Model: Cohort;   Time Perspective: Prospective
Condition: Serious Mental Illness

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Maryland Assessment of Recovery in Serious Mental Illness Individuals with serious mental illness treated in mental health outpatient programs

Participant Flow:   Overall Study
    Maryland Assessment of Recovery in Serious Mental Illness
STARTED   250 
COMPLETED   186 
NOT COMPLETED   64 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Maryland Assessment of Recovery in Serious Mental Illness Individuals with serious mental illness treated in VA mental health outpatient programs

Baseline Measures
   Maryland Assessment of Recovery in Serious Mental Illness 
Overall Participants Analyzed 
[Units: Participants]
 250 
Age 
[Units: Years]
Mean (Standard Deviation)
 51.3  (8.4) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
 
Female      44  17.6% 
Male      206  82.4% 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Positive and Negative Symptom Scale (PANSS)   [ Time Frame: ~1-year ]

2.  Secondary:   Maryland Assessment of Recovery in Serious Mental Illness   [ Time Frame: ~ 1-year ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Dr. Amy Drapalski
Organization: VISN 5 MIRECC
phone: 410-637-1855
e-mail: amy.drapalski@va.gov



Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT01043653     History of Changes
Other Study ID Numbers: D7156-R
Study First Received: January 5, 2010
Results First Received: November 10, 2016
Last Updated: January 25, 2017